loadpatents
name:-0.028273105621338
name:-0.012392997741699
name:-0.0070250034332275
Nandi; Indranil Patent Filings

Nandi; Indranil

Patent Applications and Registrations

Patent applications and USPTO patent grants for Nandi; Indranil.The latest application filed is for "modified release suspension of eslicarbazepine".

Company Profile
7.11.30
  • Nandi; Indranil - Yardley PA
  • Nandi; Indranil - Bridgewater NJ
  • NANDI; Indranil - New Providence NJ
  • Nandi; Indranil - Plainsboro NJ
  • Nandi; Indranil - Mahwah NJ
  • Nandi; Indranil - Iselin NJ
*profile and listings may contain filings by different individuals or companies with the same name. Review application materials to confirm ownership/assignment.
Patent Activity
PatentDate
Modified Release Suspension Of Eslicarbazepine
App 20220273670 - Kumar; Dinesh ;   et al.
2022-09-01
Eslicarbazepine Suspension
App 20220265552 - Nandi; Indranil ;   et al.
2022-08-25
Extended Release Pharmaceutical Compositions Of Riociguat
App 20220202698 - Nandi; Indranil ;   et al.
2022-06-30
Modified release suspension of eslicarbazepine
Grant 11,331,324 - Kumar , et al. May 17, 2
2022-05-17
Preparation of angiotensin receptor blockers or pharmaceutically acceptable salts thereof
Grant 11,327,065 - Thomas , et al. May 10, 2
2022-05-10
Eslicarbazepine suspension
Grant 11,318,145 - Nandi , et al. May 3, 2
2022-05-03
Parenteral dosage form of .beta.3 adrenoreceptor agonists
Grant 11,311,518 - Nandi , et al. April 26, 2
2022-04-26
Methods And Compositions Of Solabegron For Reducing Body Fat
App 20220062213 - Nandi; Indranil
2022-03-03
Pharmaceutical Compositions Of Vibegron For Reducing Body Fat
App 20220062288 - Nandi; Indranil
2022-03-03
Pharmaceutical Composition of Chlordiazepoxide and Clidinium Combination
App 20220040196 - Nandi; Indranil ;   et al.
2022-02-10
Long-acting Injection Dosage Form Of Beta 3 Adrenoreceptor Agonists
App 20220000843 - Nandi; Indranil ;   et al.
2022-01-06
Transmucosal Pharmaceutical Compositions Of Antiviral Drugs
App 20210369619 - Nandi; Indranil ;   et al.
2021-12-02
Continuous Process For The Preparation Of 2-(1h-imidazol-4-yl) Ethanamine And Pharmaceutically Acceptable Salts Thereof
App 20210361785 - Kumar; Sanjeev ;   et al.
2021-11-25
Dual Release Pharmaceutical Compositions Comprising The Combination Of A Beta-3 Adrenoreceptor Agonist And A Muscarinic Receptor Antagonist
App 20210353546 - Nandi; Indranil ;   et al.
2021-11-18
Midodrine Hydrochloride Oral Solution And Uses Thereof
App 20210322345 - Nandi; Indranil ;   et al.
2021-10-21
High Drug Load Solid Oral Dosage Forms Of Dexamethasone
App 20210275546 - Nandi; Indranil
2021-09-09
Eslicarbazepine Suspension
App 20210275539 - Nandi; Indranil ;   et al.
2021-09-09
Self-emulsifying Solid Oral Dosage Forms Of Allergen And Their Preparation Thereof
App 20210236628 - Nandi; Indranil
2021-08-05
Self-emulsifying Dosage Forms Of Allergen And Their Preparation Thereof
App 20210236629 - Nandi; Indranil
2021-08-05
Transmucosal dosage forms of remdesivir
Grant 11,020,349 - Nandi , et al. June 1, 2
2021-06-01
Midodrine hydrochloride oral solution and uses thereof
Grant 11,013,702 - Nandi , et al. May 25, 2
2021-05-25
Method For Determining In Vitro Bioequivalence Of A Sucralfate Suspension Sample To A Sucralfate Suspension Reference Listed Drug (rld)
App 20210148893 - Bhoopathy; Siddhartha ;   et al.
2021-05-20
Continuous process for the preparation of 2-(1H-imidazol-4-yl) ethanamine and pharmaceutically acceptable salts thereof
Grant 10,889,549 - Kumar , et al. January 12, 2
2021-01-12
Modified Release Suspension Of Eslicarbazepine
App 20200222421 - Kumar; Dinesh ;   et al.
2020-07-16
Eslicarbazepine Suspension
App 20200222420 - Kumar; Dinesh ;   et al.
2020-07-16
Continuous Process For The Preparation Of 2-(1h-imidazol-4-yl) Ethanamine And Pharmaceutically Acceptable Salts Thereof
App 20200131137 - Kumar; Sanjeev ;   et al.
2020-04-30
Midodrine Hydrochloride Oral Solution And Uses Thereof
App 20200113851 - Nandi; Indranil ;   et al.
2020-04-16
Syringe
Grant D851,757 - Nandi , et al.
2019-06-18
Syringe
Grant D836,772 - Nandi , et al. Dec
2018-12-25
Method for determining in vitro bioequivalence of a sucralfate suspension sample to a sucralfate suspension reference listed drug (RLD)
Grant 9,989,519 - Bhoopathy , et al. June 5, 2
2018-06-05
Antibiotic clarithromycin micropellet compositions
Grant 8,168,228 - Nandi , et al. May 1, 2
2012-05-01
Solid multilayer oral dosage forms
App 20090186086 - Shankar; Sabarinath ;   et al.
2009-07-23
Antibiotic compositions
App 20070134344 - Nandi; Indranil ;   et al.
2007-06-14
Compression coated tablets
App 20060193915 - Guo; Mintong ;   et al.
2006-08-31
Alendronate salt tablet compositions
App 20050181043 - Nandi, Indranil ;   et al.
2005-08-18
Lansoprazole microtablets
App 20050181052 - Patel, Satishkumar Ambalal ;   et al.
2005-08-18
Antibiotic compositions
App 20050084541 - Nandi, Indranil ;   et al.
2005-04-21
Taste masking antibiotic composition
App 20050084540 - Nandi, Indranil ;   et al.
2005-04-21
Fexofenadine composition and process for preparing
App 20050065183 - Nandi, Indranil ;   et al.
2005-03-24
Pharmaceutical composition for solubility enhancement of hydrophobic drugs
App 20050008704 - Ray, Anup Kumar ;   et al.
2005-01-13
Compression coated tablets
App 20040068000 - Guo, Mintong ;   et al.
2004-04-08

uspto.report is an independent third-party trademark research tool that is not affiliated, endorsed, or sponsored by the United States Patent and Trademark Office (USPTO) or any other governmental organization. The information provided by uspto.report is based on publicly available data at the time of writing and is intended for informational purposes only.

While we strive to provide accurate and up-to-date information, we do not guarantee the accuracy, completeness, reliability, or suitability of the information displayed on this site. The use of this site is at your own risk. Any reliance you place on such information is therefore strictly at your own risk.

All official trademark data, including owner information, should be verified by visiting the official USPTO website at www.uspto.gov. This site is not intended to replace professional legal advice and should not be used as a substitute for consulting with a legal professional who is knowledgeable about trademark law.

© 2024 USPTO.report | Privacy Policy | Resources | RSS Feed of Trademarks | Trademark Filings Twitter Feed